tailieunhanh - Meta-analysis of Osteopontin splice variants in cancer

The cytokine Osteopontin is a mediator of tumor progression and cancer metastasis. In 2006, we reported that (in addition to the full-length form -a) splice variants of Osteopontin (forms -b and -c) are produced selectively by transformed cells. Through June 2021, 36 PubMed-indexed journal articles have studied Osteopontin splice variants in various cancer patients. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN